TBCE and metabolic disease: This evolutionarily conserved transmembrane protein (Hopfner and Hornung, 2020) has been shown to contribute to the development of inflammation, connective tissue proliferation, and metabolic disorders in the liver by activating KCs and HSCs (Chen et al., 2021a; Chen et al., 2021b).